Multiple presentations on vimseltinib for the treatment of Tenosynovial Giant Cell Tumor (TGCT), including encore data from the Phase 3 MOTION study presented in an oral session -- -- Two posters on ...

Phase 3 TRANSCEND trial data showed setmelanotide achieved significant BMI reductions in patients with acquired hypothalamic obesity on ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for indications in virology and ...

Blue Fin Vision and Zeiss Medical Technology have announced their partnership on a new series of international presentations by Mr Mfazo Hove.

TG Therapeutics will present data on BRIUMVI for relapsing multiple sclerosis at the ACTRIMS forum, February 27 – March 1, 2025. TG Therapeutics, Inc. announced the schedule for presentations on data ...

CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic ...

The latest announcement is out from Global Medical REIT (GMRE). Global Medical REIT Inc. has recently refreshed its investor presentation, which is now available on their website’s “Investors” section ...

From the Series Mania conference in Lille, France, Ampere Analysis‘ Guy Bisson and Cyrine Amor took to the stage Tuesday, armed with data, insights and a keen understanding of the seismic shifts in ...

WUHU, China, Oct. 19, 2025 /PRNewswire/ -- At the 2025 Chery Global Innovation Conference, an extraordinary "guest" took the stage — Mornine, the intelligent robot from AiMOGA Robotics. Opening in ...

Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that written materials accompanying the Company’s upcoming presentation at the BofA ...